Page last updated: 2024-08-18

2-aminopyrimidine and Cancer of Pancreas

2-aminopyrimidine has been researched along with Cancer of Pancreas in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, L; Li, X; Li, Y; Ma, X; Sun, X; Tian, L; Wang, C; Wu, B; Yu, J; Zheng, X	1

Other Studies

1 other study(ies) available for 2-aminopyrimidine and Cancer of Pancreas

Article	Year
Design, synthesis and activity evaluation of isopropylsulfonyl-substituted 2,4- diarylaminopyrimidine derivatives as FAK inhibitors for the potential treatment of pancreatic cancer. European journal of medicinal chemistry, 2022, Nov-05, Volume: 241 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mice; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines	2022

Article

Year

Design, synthesis and activity evaluation of isopropylsulfonyl-substituted 2,4- diarylaminopyrimidine derivatives as FAK inhibitors for the potential treatment of pancreatic cancer.

European journal of medicinal chemistry, 2022, Nov-05, Volume: 241

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mice; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines

2022